Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Ovintiv, The Mosaic Co, Deere, Crocs and Select Medical Holdings

Read MoreHide Full Article

For Immediate Release

Chicago, IL – March 4, 2021 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ovintiv Inc. (OVV - Free Report) , The Mosaic Company (MOS - Free Report) , Deere & Company (DE - Free Report) , Crocs Inc. (CROX - Free Report) and Select Medical Holdings Corp. (SEM - Free Report) .

Here are highlights from Wednesday’s Analyst Blog:

5 Top-Ranked Momentum Stocks to Override March Volatility

Wall Street is reeling under volatility, which crept up in the second half of last month. However, despite facing severe market fluctuations, all the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — ended in green in February. Moreover, year to date, these indexes are in positive territory after finishing an impressive 2020 defying coronavirus.

Markets may witness fluctuations in the near future. The fear gauge — CBOE VIX — has refused to stay below 20 since Feb 12. Nevertheless, stock markets will remain northbound as the economy will gradually reopen supported by COVID-19 vaccinations. Additionally, the fundamentals of the U.S. economy remain strong as evident by several recently released data.  

Momentum Likely to Continue

Momentum investing calls for a continued appraisal of stocks, ensuring that an investor does not pick a beaten-down name or overlook a thriving one. Momentum investors buy high on the anticipation that a stock will only ascend in the short to intermediate term.

In December 2020, the U.S. Congress had approved $900 billion of stimulus including one-time cash payments of $600 and a special weekly unemployment benefit of $300. Consequently, personal income climbed 10%, marking the second-highest monthly increase on record. Personal expenditure rose 2.4% — the first gain in three months and the biggest monthly increase since June 2020. Additionally, the savings rate jumped 20.5% in January from 13.4% in the previous month.

Goldman Sachs reported that the total savings of U.S. citizens could climb to $2.4 trillion by mid-2021. On Feb 27, the House of Representatives passed President Joe Biden's proposed $1.9 trillion fresh coronavirus-aid package. If the Senate passes this bill, massive savings along with further stimulus will significantly boost the pent-up demand for U.S. consumers.

A section of economists are skeptical that robust pent-up demand and shortage of inputs due to COVID-19 related restrictions will result in both demand-pull and cost-push inflation, raising the general price level.

Meanwhile, in January, the core (excluding volatile food and energy items) PCE index — Fed's favorite gauge of inflation — rose 1.5%, year over year, which is well below the central bank's 2% target rate. This supports Fed Chairman Jerome Powell's repeated confirmation of pursuing ultra-dovish monetary policies for a longer period.

In its latest prediction on Mar 1, the Atlanta Fed estimated that the U.S. GDP will jump 10% in the first quarter of 2021. On Feb 11, the Wall Street Journal reported that economists on average expect U.S. GDP to expand nearly 4.9% this year from 4.3% in January.

Notably, in its second estimate, the Department of Commerce has revised fourth-quarter GDP growth to 4.1% from 4% reported earlier. This means that at the end of 2020, total goods and services produced were just about $270 billion less than at the end of 2019. On Feb 1, the Congressional Budget Office projected that the economy is expected to reach the pre-pandemic level of February 2020 by mid-2021.

Our Top Picks

At this stage, it will be fruitful to invest in momentum stocks with a favorable Zacks Rank. We have narrowed down our search to five momentum stocks that have popped more than 20% year to date and have strong upside left for 2021.

These stocks have witnessed robust earnings estimate revisions in the last 7 days highlighting solid business prospects. Each of our picks carries a Zacks Rank #1 (Strong Buy) and has a Momentum Score of A.  You can see the complete list of today’s Zacks #1 Rank stocks here.

The chart below shows the price performance of our five picks year to date.

Ovintiv is engaged in the exploration, development, production, and marketing of natural gas, oil, and natural gas liquids. It operates through USA Operations, Canadian Operations, and Market Optimization segments.

The company has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 27.3% over the last 7 days. The stock price has soared 72.3% year to date.

The Mosaic Co produces and markets concentrated phosphate and potash crop nutrients in North America and internationally. It operates through three segments: Phosphates, Potash, and Mosaic Fertilizantes.

The company has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 10.2% over the last 7 days. The stock price has jumped 35.7% year to date.

Deere manufactures and distributes farm equipment worldwide. It operates through three segments: Agriculture and Turf, Construction and Forestry, and Financial Services.

The company has an expected earnings growth rate of 80.3% for the current year (ending October 2021). The Zacks Consensus Estimate for current-year earnings has improved 2.2% over the last 7 days. The stock price has climbed 30.1% year to date.

Crocs designs, develops, manufactures, markets and distributes casual lifestyle footwear and accessories for men, women and children worldwide. It offers various footwear products, including clogs, sandals, flips and slides, shoes, and boots under the Crocs brand name.

The company has an expected earnings growth rate of 20.8% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3.7% over the last 7 days. The stock price has rallied 24.9% year to date.

Select Medical Holdings operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States.

The company has an expected earnings growth rate of 9% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 31.2% over the last 7 days. The stock price has surged 21.2% year to date.

Bitcoin, Like the Internet Itself, Could Change Everything

Blockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the “Internet of Money” and predict it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree we’re still in the early stages of this technology, and as it grows, it will create several investing opportunities.

Zacks’ has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

See 3 crypto-related stocks now >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339                                                                        


Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.